Lactobacillus for Diarrhea: Evidence-Based Recommendations
Specific Lactobacillus strains can effectively reduce the duration and severity of diarrhea, particularly in antibiotic-associated and acute infectious diarrhea, with Saccharomyces boulardii and Lactobacillus rhamnosus GG showing the strongest evidence of efficacy. 1
Efficacy of Lactobacillus in Different Types of Diarrhea
Antibiotic-Associated Diarrhea
The American Gastroenterological Association (AGA) suggests using specific probiotics for prevention of antibiotic-associated diarrhea: 2
- Saccharomyces boulardii
- The 2-strain combination of L. acidophilus CL1285 and L. casei LBC80R
- The 3-strain combination of L. acidophilus, L. delbrueckii subsp bulgaricus, and B. bifidum
- The 4-strain combination of L. acidophilus, L. delbrueckii subsp bulgaricus, B. bifidum, and S. salivarius subsp thermophilus
Dosage is critical - higher doses (≥10 billion CFU/day) show better efficacy 1
Acute Infectious Diarrhea
The European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) recommends: 2
- Saccharomyces boulardii CNCM I-745
- Lactobacillus rhamnosus GG
- Lactobacillus reuteri DSM 17938
These probiotics can reduce diarrhea duration by approximately 21.91 hours and decrease the risk of prolonged diarrhea (>3 days) by 38% 1
Clostridium difficile-Associated Diarrhea
- Evidence suggests S. boulardii may increase cessation of diarrhea (RR, 1.33; 95% CI, 1.02-1.74) and decrease recurrence (RR, 0.59; 95% CI, 0.35-0.98) 2
- However, the AGA notes that current evidence is heterogeneous and of low quality 2
Strain-Specific Efficacy
Not all Lactobacillus strains are equally effective:
Most Effective Strains:
- Lactobacillus rhamnosus GG - strong evidence for prevention of nosocomial diarrhea and treatment of acute gastroenteritis 2
- Saccharomyces boulardii - effective for antibiotic-associated diarrhea and C. difficile infection 2, 3
- Lactobacillus reuteri - effective for acute gastroenteritis, especially in breastfed infants with colic 2, 4
Less Effective or Uncertain:
Dosage and Administration
- Effective dosage: ≥10 billion CFU/day 1, 3
- Timing: Should be taken 2 hours apart from antibiotics when used for antibiotic-associated diarrhea 1
- Duration: Continue throughout antibiotic course and for 1-2 weeks after completion 1
- Multi-strain probiotics often demonstrate better outcomes than single-strain options 1, 7
Safety Considerations
- Generally safe with low adverse event rates (4% in probiotic groups vs 6% in control groups) 1
- Use with caution in:
- Premature neonates
- Immunocompromised patients
- Critically ill patients
- Patients with central venous catheters
- Patients with cardiac valvular disease
- Patients with short-gut syndrome 2
Clinical Algorithm for Probiotic Selection
For antibiotic-associated diarrhea prevention:
- First choice: S. boulardii or L. rhamnosus GG at ≥10 billion CFU/day
- Alternative: Multi-strain combinations as recommended by AGA
For acute infectious diarrhea treatment:
- First choice: L. rhamnosus GG or S. boulardii at ≥10 billion CFU/day
- Alternative: L. reuteri (especially in breastfed infants)
For C. difficile infection:
- Consider S. boulardii as adjunct to appropriate antibiotic therapy
- Avoid L. rhamnosus ATCC 53103 due to potential increased recurrence
For high-risk patients (immunocompromised, critically ill):
- Avoid probiotics due to safety concerns
Remember that rehydration remains the primary treatment for diarrhea, with probiotics serving as adjunctive therapy 1.